Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.
复制标题
DOI:
10.1038/s41467-018-04216-6
复制
发表时间:
2018-05-15
影响因子:
16.6
通讯作者:
Morrison TG
中科院分区:
文献类型:
--
作者:
Blanco JCG;Pletneva LM;McGinnes-Cullen L;Otoa RO;Patel MC;Fernando LR;Boukhvalova MS;Morrison TG
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in infants. Maternal immunization is an option to increase maternal antibody levels and protect infants from infection. Here we assess the efficacy of virus-like particle (VLP) vaccine candidates containing stabilized pre-fusion (pre-F) or post-fusion (post-F) conformations of the RSV F protein and the attachment RSV G protein in a maternal immunization model using cotton rats. VLP vaccines containing RSV F and G proteins strongly boost pre-existing RSV immunity in dams preventing their perinatal drop in immunity. Boosting is stronger for the pre-F VLP than for the post-F VLP or purified subunit F protein vaccines, giving an advantage on mothers’ protection. VLP immunization of dams provides significant protection to pups from RSV challenge and reduced pulmonary inflammation. Collectively, our results show that a VLP vaccine with RSV F and G proteins is safe and effective for maternal and adult vaccination. RSV infection is a major cause of bronchiolitis in infants and maternal vaccination is a potential preventive option. Here, Blanco et al. show efficacy of a Newcastle disease virus-based virus-like particle vaccine candidate in naive and pre-exposed cotton rat dams and their offspring.